2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Daniel Lin

759 views

August 6, 2020

Comments 1

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

375 views

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

139 views

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Debbie's Dream Foundation

S. Klempner

177 views

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

164 views

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

2024 ESMO Annual Meeting Insights Hub

A. Kawazoe

155 views

New

Treatment Updates in the Management of Metastatic Gastroesophageal C…

Total Health

S. Chokshi

64 views

Nutrition Oncology: A New Frontier

UCLA Health

M. Garcia

739 views

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

1.1K views

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Nebraska Oncology Society

R. Safyan

106 views

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

Yale Cancer Center

J. Lacy

133 views

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Yale Cancer Center

C. Balch

347 views

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

2024 ASCO® Annual Meeting Insights Hub

R. Sundar

134 views

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Elizabeth Smyth

R. Sundar

242 views

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

442 views

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab …

2024 ASCO® Annual Meeting Insights Hub

H. Yoon

145 views

Additional Advances in Esophagogastric Cancer Research and Clinical …

Oncology Data Advisor

J. Ajani

138 views

ESMO 2024 Summary: Frontline Upper GI Treatment Highlights

COR2ED The Heart of Medical Education

S. Klempner, E. Smyth

39 views

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal…

2024 ASCO® Annual Meeting Insights Hub

A. Shreenivas, S. Chakrabarti

135 views

Esophageal Cancer

Indiana University School of Medicine Division of Gastroenterology and Hepatology

S. Jalal

36 views

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Integrity CE

K. Bever, R. Voong, J. Hernandez, S. Klempner

151 views

AUTOPLAY

Login

Login

Join VuMedi

2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Related Videos

Recent Updates in Upper Gl Cancers

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

Gastroesophageal Cancer Updates From 2024 Summer Conferences

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

Treatment Updates in the Management of Metastatic Gastroesophageal C…

Nutrition Oncology: A New Frontier

Year in Review: Upper GI Cancers

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab …

Additional Advances in Esophagogastric Cancer Research and Clinical …

ESMO 2024 Summary: Frontline Upper GI Treatment Highlights

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal…

Esophageal Cancer

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…